Burden of Peripheral Artery Disease and Its Attributable Risk Factors in 204 Countries and Territories From 1990 to 2019

Abstract

BackgroundData on burden of peripheral artery disease (PAD) and its attributable risk factors are valuable for policymaking. We aimed to estimate the burden and risk factors for PAD from 1990 to 2019.MethodsWe extracted the data on prevalence, incidence, death, years lived with disability (YLDs), and years of life lost (YLLs) from the Global Burden of Disease Study 2019 to measure PAD burden. Moreover, the attributable burden to PAD risk factors was also estimated.ResultsGlobally, in 2019, 113,443,017 people lived with PAD and 10,504,092 new cases occurred, resulting in 74,063 deaths, 500,893 YLDs, and 1,035,487 YLLs. The absolute numbers of PAD prevalent and incident cases significantly increased between 1990 and 2019, contrasting with the decline trends in age-standardized prevalence and incidence rates. However, no statistically significant changes were detected in the global age-standardized death or YLL rates. The burden of PAD and its temporal trends varied significantly by location, gender, age group, and social-demographic status. Among all potentially modifiable risk factors, age-standardized PAD deaths worldwide were primarily attributable to high fasting plasma glucose, followed by high systolic blood pressure, tobacco, kidney dysfunction, diet high in sodium, and lead exposure.ConclusionPAD remained a serious public health problem worldwide. More strategies aimed at implementing cost-effective interventions and addressing modifiable risk factors should be carried out, especially in regions with high or increasing burden.

Sex-Based Differences in Clinical Characteristics and Outcomes among Patients with Peripheral Artery Disease: A Retrospective Analysis

“…The prevalence of PAD is increasing worldwide, especially in low-and middle-income countries [21], and it remains frequently underdiagnosed due to a lack of physician and patient awareness [4]. The 5-year follow-up of asymptomatic PAD patients shows a 7% chance of developing CI and cardiovascular mortality is higher in these patients [22].…”

A modern day perspective on smoking in peripheral artery disease

“…Overall, the burden of smoking-related PAD deaths has declined modestly in both men and women over the past three decades due to the intense regulatory and public education efforts. Yet, in 2019, nearly a quarter of PAD-related deaths remain attributable to tobacco use globally (8). Secondhand smoke exposure confirmed by urinary cotinine levels has also been linked to clinical PAD (9).…”

Optical and X-ray attenuation properties of hafnium oxide nanoparticles surface functionalized with fucoidan: toward the early diagnosis of atherothrombotic diseases

“…Atherothrombotic events represent the main cause of mortality and morbidity in the world, 1,2 involving both the arterial and the venous part of the circulation: myocardial infarction, ischemic stroke, aneurysms, peripheral arterial disease, atrial thrombus and embolisms, phlebothrombosis and pulmonary embolisms. Many thrombotic events could be diagnosed before dramatic complications occur.…”